Furthermore, the precise role of plant-derived SAC-Par-4 as a potent anti-prostate cancer agent needs to be evaluated in reference to its activity against normal prostate cell lines such as PNT1 A/B or PNT2. This evidence concerns the gene PAWR and prostate carcinoma.